Male (n=162) | Female (n=163) | Total (n=325) | |
---|---|---|---|
Basal cell carcinoma | 141 (87.1%) | 132 (81.0%) | 273 (84.0%) |
Sebaceous adenocarcinoma | 10 (6.2%) | 23 (14.1%) | 33 (10.2%) |
Squamous cell carcinoma | 5 (3.1%) | 6 (3.7%) | 11 (3.4%) |
Malignant melanoma | 2 (1.2%) | 2 (1.2%) | 4 (1.2%) |
Other diagnoses | 4 (2.4%) | 0 (0.0%) | 4 (1.2%) |
Chinese (n=296) |
Malay (n=17) | Indian (n=10) |
Others (n=2) | |
Basal cell carcinoma | 245 (82.8%) | 16 (94.1%) | 10 (100%) | 2 (100%) |
Sebaceous adenocarcinoma | 32 (10.8%) | 1 (5.9%) | 0 | 0 |
Squamous cell carcinoma | 11 (3.6%) | 0 | 0 | 0 |
Malignant melanoma | 4 (1.4%) | 0 | 0 | 0 |
Other diagnoses | 4 (1.4%) | 0 | 0 | 0 |